SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Euromonitor International | PRODUCT CODE: 2188807

Cover Image

PUBLISHER: Euromonitor International | PRODUCT CODE: 2188807

Consumer Health in Italy

PUBLISHED:
PAGES: 257 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 2925

Add to Cart

Consumer health in Italy in 2026 is recording steady value expansion as growth becomes increasingly dependent on pricing rather than volume, amid demographic pressures and constrained real GDP growth. The industry is attractive due to its resilience and evolving consumer preferences, especially as manufacturers pivot to solutions for chronic health and prevention, responding to an ageing population and heightened demand for usability and convenience. Success now requires brands to balance establ...

Euromonitor International's Consumer Health in Italy report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2021-2025, allowing you to identify the sectors driving growth. Forecasts to 2030 illustrate how the market is set to change.

Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

  • Get a detailed picture of the Consumer Health market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market's major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 50 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo, Bengaluru, Sao Paulo, Seoul, Hong Kong, Dusseldorf and Mexico City and a network of analysts in 100 countries, Euromonitor International has a unique capability and an understanding of diverse markets to develop reliable information resources to help drive informed strategic planning. To learn more about how our research solutions can support you, contact your local Euromonitor International office.

Product Code: CHIT

TABLE OF CONTENTS

List Of Contents And Tables

Executive Summary

  • 2026 Developments

Key Data Insights

Key Industry Trends

    • CHART 1 Key Industry Trends for Consumer Health

Industry Performance

  • Prevention and Risk Perception Reshape Italy'S Consumer Health in 2026
  • Demographic Transformation and Chronic Health Needs Redefine Environment
  • Shifting Trust Dynamics Influences Certification and Transparency Appeal
    • CHART 2 Value Sales 2021-2031
    • CHART 3 Value Sales by Category 2026

What's Next?

  • Prevention, Polarisation and Generational Divide to Define Italy'S Consumer Health Outlook
    • CHART 4 Analyst Insight for Consumer Health
  • Sports Nutrition Growth and Pharmacy Channel Evolution to Shape Italy'S Consumer Health
    • CHART 5 Forecast Value Sales 2021-2031
    • CHART 6 Forecast Value Sales by Category 2026-2031

Competitive Landscape

  • The Top Manufacturers Shape Diverging Models for Sustained Lead
    • CHART 7 Company Shares 2026
    • CHART 8 Brand Shares 2026

Channels

  • Pharmacies Reinforce Trust through Guidance and Professional Reassurance
  • Channel Evolution Reshapes Italy'S Consumer Health as Digital Gains, Direct Selling Declines
    • CHART 9 Retail Channels 2021-2026

Products

  • Manufacturers Redesign Solutions as Ageing Reshapes Product Priorities
    • CHART 10 Manufacturers Product Redesign
  • Brands Expand Prevention and Multifunctionality to Capture Changing Health Behaviours
    • CHART 11 Preventative Care Transition
  • Heritage, Science and Advice Drive Trust and Channel Strategy

Economic Context

    • CHART 12 Economic Context for Consumer Health
    • CHART 13 Real GDP Growth 2021-2031
    • CHART 14 Inflation 2021-2031

Consumer Context

    • CHART 15 Consumer Context for Consumer Health
    • CHART 16 Population 2021-2031
    • CHART 17 Population by Generation 2026
    • CHART 18 Consumer Expenditure 2021-2031
  • Country Reports Disclaimer

ANALGESICS IN ITALY

Key Data Insights

  • 2026 Developments
  • Analgesics Summary

Key Industry Trends

    • CHART 19 Key Industry Trends for Analgesics

Industry Performance

  • Preventive Health Shift and Structural Constraints Mute Italy'S Analgesics Growth
  • Systemic Analgesics Lead by Value as Topical Formats Capture Stronger Growth
  • Online Expansion and Service-Led Differentiation Define Retail Shift
    • CHART 20 Value Sales 2021-2031
    • CHART 21 Value Sales by Category 2026

What's Next?

  • Brands to Prioritise Product Differentiation to Retain Value as Generics Grow
  • Systemic Options to Dominate as Tailored Solutions Drive Loyalty
    • CHART 22 Analyst Insight for Analgesics
    • CHART 23 Forecast Value Sales 2021-2031
    • CHART 24 Forecast Value Sales by Category 2026-2031

Competitive Landscape

  • Tachipirina and Voltaren Reinforce Brand Leadership
    • CHART 25 Company Shares 2026
    • CHART 26 Brand Shares 2026

Channels

  • Pharmacies Maintain Shopper Loyalty as Digital Platforms Expand
    • CHART 27 Retail Channels 2021-2026

Products

  • Bayer and Reckitt Target Shifting Demand with New Formats
    • CHART 28 Age-Friendly Formats

Economic Context

    • CHART 29 Economic Context for Analgesics
    • CHART 30 Real GDP Growth 2021-2031
    • CHART 31 Inflation 2021-2031

Consumer Context

    • CHART 32 Consumer Context for Analgesics
    • CHART 33 Population 2021-2031
    • CHART 34 Population by Generation 2026
    • CHART 35 Consumer Expenditure 2021-2031
  • Country Reports Disclaimer

SLEEP AIDS IN ITALY

Key Data Insights

  • 2026 Developments
  • Sleep Aids Summary

Key Industry Trends

    • CHART 36 Key Industry Trends for Sleep Aids

Industry Performance

  • Workplace Regulation Legitimises Sleep Support as Essential Wellbeing
    • CHART 37 Modern Work Patterns and Sleep Disruption
  • Natural Rest Solutions Appeal to Everyday Consumers
  • Innovation Stalls as Italian Sleep Aids Clone Each Other
    • CHART 38 Value Sales 2021-2031

What's Next?

  • Targeted Sleep Solutions to Gain Ground as Broad Claims Lose Impact
  • Evolving Regulatory Winds to Set the Stage for Sleep Aid Growth
    • CHART 39 Forecast Value Sales 2021-2031

Competitive Landscape

  • Procter & Gamble Italia Spa Leverages Habitual Routines to Reinforce Repeat Purchase
    • CHART 40 Company Shares 2026
    • CHART 41 Brand Shares 2026

Channels

  • Pharmacy Drives Trust as Grocers and E-Commerce Gain Ground
    • CHART 42 Retail Channels 2021-2026

Products

  • Equilibra Broadens Sleep Support with Triple-Layer Botanicals
    • CHART 43 Rise in Preventative Sleep Systems
  • Eurospin Matches Branded Sleep Aid Systems to Capture Price-Led Shoppers

Economic Context

    • CHART 44 Economic Context for Sleep Aids
    • CHART 45 Real GDP Growth 2021-2031
    • CHART 46 Inflation 2021-2031

Consumer Context

    • CHART 47 Consumer Context for Sleep Aids
    • CHART 48 Population 2021-2031
    • CHART 49 Population by Generation 2026
    • CHART 50 Consumer Expenditure 2021-2031
  • Country Reports Disclaimer

COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN ITALY

Key Data Insights

  • 2026 Developments
  • Cough, Cold and Allergy (Hay Fever) Remedies Summary

Key Industry Trends

    • CHART 51 Key Industry Trends for Cough, Cold and Allergy (Hay Fever) Remedies

Industry Performance

  • Prevention Shift, Climate Convergence and Channel Strain Drive Remedies Transformation
  • Cough Remedies Dominate Value as Allergy Products Provide Stability
    • CHART 52 Value Sales 2021-2031
    • CHART 53 Value Sales by Category 2026

What's Next?

  • Generic Antihistamines to Capture Growth as Brands Lose Pricing Power
  • Allergy Remedies and Medicated Confectionery to Lead Remedy Transformation
    • CHART 54 Analyst Insight for Cough, Cold and Allergy (Hay Fever) Remedies
    • CHART 55 Forecast Value Sales 2021-2031
    • CHART 56 Forecast Value Sales by Category 2026-2031

Competitive Landscape

  • Bronchenolo Leverages Heritage While Grintuss Capitalises on Natural Shift
    • CHART 57 Company Shares 2026
    • CHART 58 Brand Shares 2026

Channels

  • Pharmacies Maintain Dominance as Online Platforms Intensify Price Competition
    • CHART 59 Retail Channels 2021-2026

Products

  • Hypertonic Solutions and Multifunctional Formats Reshape Consumer Habits
    • CHART 60 Public Health Messaging

Economic Context

    • CHART 61 Economic Context for Cough, Cold and Allergy (Hay Fever) Remedies
    • CHART 62 Real GDP Growth 2021-2031
    • CHART 63 Inflation 2021-2031

Consumer Context

    • CHART 64 Consumer Context for Cough, Cold and Allergy (Hay Fever) Remedies
    • CHART 65 Population 2021-2031
    • CHART 66 Population by Generation 2026
    • CHART 67 Consumer Expenditure 2021-2031
  • Country Reports Disclaimer

DERMATOLOGICALS IN ITALY

Key Data Insights

  • 2026 Developments
  • Dermatologicals Summary

Key Industry Trends

    • CHART 68 Key Industry Trends for Dermatologicals

Industry Performance

  • Diverging Performance and Preventive Shifts Reshape Italy'S Dermatologicals
  • Otc Dermatologicals Lose Ground to Beauty-Health Hybrids
  • Tiger Mosquito Expansion Drives Sustained Demand for Antipruritics
    • CHART 69 Value Sales 2021-2031
    • CHART 70 Value Sales by Category 2026

What's Next?

  • Dermocosmetic Brands to Expand Routines and Challenge Otc Leaders
  • Antipruritics to Lead Value Growth as Topical Antifungals Maintain Scale
  • Hair Loss Treatments to Leverage Clinical Evidence for Premium Growth
    • CHART 71 Forecast Value Sales 2021-2031
    • CHART 72 Forecast Value Sales by Category 2026-2031

Competitive Landscape

  • Fragmentation and Portfolio Differentiation Define Competitive Landscape
  • Strategic Acquisitions and Pending Offers Drive Competitive Repositioning
    • CHART 73 Company Shares 2026
    • CHART 74 Brand Shares 2026

Channels

  • Pharmacies Sustain Their Lead as E-Commerce Shapes Routine Purchases
    • CHART 75 Retail Channels 2021-2026

Products

  • Herpmed Labiale and Canesten Reshape Routines with Format-Driven Innovation
    • CHART 76 Herpmed Labiale Drives Format Innovation
  • Device-Based Solutions Redefine Insect Bite Relief and Urban Convenience
    • CHART 77 Device-Based Relief Models

Economic Context

    • CHART 78 Economic Context for Dermatologicals
    • CHART 79 Real GDP Growth 2021-2031
    • CHART 80 Inflation 2021-2031

Consumer Context

    • CHART 81 Consumer Context for Dermatologicals
    • CHART 82 Population 2021-2031
    • CHART 83 Population by Generation 2026
    • CHART 84 Consumer Expenditure 2021-2031
  • Country Reports Disclaimer

DIGESTIVE REMEDIES IN ITALY

Key Data Insights

  • 2026 Developments
  • Digestive Remedies Summary

Key Industry Trends

    • CHART 85 Key Industry Trends for Digestive Remedies

Industry Performance

  • Polarisation, Prevention and Regulatory Shifts Reshape Italy's Digestive Remedies
  • Gut-Brain Connection and Prescription-To-Otc Shift Anchor Digestion Remedies'
    • CHART 86 Value Sales 2021-2031
    • CHART 87 Value Sales by Category 2026

What's Next?

  • Ibs Treatments and Indigestion Remedies to Drive Italy'S Digestive Remedies Growth
  • Natural Credibility and Polarisation between Generics and Premium to Define Outlook
    • CHART 88 Forecast Value Sales 2021-2031
    • CHART 89 Forecast Value Sales by Category 2026-2031

Competitive Landscape

  • Opella Healthcare Italy Srl Strengthens Leadership as Natural Solutions Gain Momentum
    • CHART 90 Company Shares 2026
    • CHART 91 Brand Shares 2026

Channels

  • Pharmacies Reinforce Leadership as Prescription Care Declines
  • Retail E-Commerce Expands in Routine Management but Remains Selective
    • CHART 92 Retail Channels 2021-2026

Products

  • Buscoibs Reposition Therapies to Drive Long-Term Engagement
    • CHART 93 Buscoibs Exemplifies Repositioning
  • Iberogast and Dulcosoft Sustain Popularity as Prevention Reshapes Purchasing
    • CHART 94 Iberogast Reflects Gut-Brain Axis

Economic Context

    • CHART 95 Economic Context for Digestive Remedies
    • CHART 96 Real GDP Growth 2021-2031
    • CHART 97 Inflation 2021-2031

Consumer Context

    • CHART 98 Consumer Context for Digestive Remedies
    • CHART 99 Population 2021-2031
    • CHART 100 Population by Generation 2026
    • CHART 101 Consumer Expenditure 2021-2031
  • Country Reports Disclaimer

EYE CARE IN ITALY

Key Data Insights

  • 2026 Developments
  • Eye Care Summary

Key Industry Trends

    • CHART 102 Key Industry Trends for Eye Care

Industry Performance

  • Screen Exposure and Occupational Health Recognition Reshapes Landscape
  • Preventative Management and Premium Formats Propel Allergy Care
  • Fragmentation and Formulation Complexity Make Pharmacist Guidance Essential
    • CHART 103 Value Sales 2021-2031
    • CHART 104 Value Sales by Category 2026

What's Next?

  • Lipid-Based Eye Drops to Attract Frequent Users Seeking Long-Term Relief
  • Pharmacist Engagement to Shape Premium Uptake in Complex Retail Environments
  • Paediatric Digital Strain to Create Untapped Demand for Screen-Specific Solutions
    • CHART 105 Forecast Value Sales 2021-2031
    • CHART 106 Forecast Value Sales by Category 2026-2031

Competitive Landscape

  • Recordati Spa and Montefarmaco Spa'S Broad Offer and Pharmacist Trust Secure Leadership
    • CHART 107 Company Shares 2026
    • CHART 108 Brand Shares 2026

Channels

  • Pharmacists Steer First-Trial Choices as Pharmacies Retain Dominance
  • E-Commerce Builds Momentum as a Repurchase Destination
    • CHART 109 Retail Channels 2021-2026

Products

  • Systane Drives Premiumisation through Daily Use and Prevention
    • CHART 110 Systane Premium Value
  • Recordati'S Eumill Allergy Sets New Baseline for Eye Care
    • CHART 111 Eumill Long Allergy Treatment Behaviour
  • Iridina'S Breadth and Pharmacist Trust Secure First-Choice Status

Economic Context

    • CHART 112 Economic Context for Eye Care
    • CHART 113 Real GDP Growth 2021-2031
    • CHART 114 Inflation 2021-2031

Consumer Context

    • CHART 115 Consumer Context for Eye Care
    • CHART 116 Population 2021-2031
    • CHART 117 Population by Generation 2026
    • CHART 118 Consumer Expenditure 2021-2031
  • Country Reports Disclaimer

NRT SMOKING CESSATION AIDS IN ITALY

Key Data Insights

  • 2026 Developments
  • Nrt Smoking Cessation Aids Summary

Industry Performance

  • Heated Tobacco Brands Divert Smokers Away From Pharmacy Products
    • CHART 119 Nicorette Quick Highlights Format Innovation Limits
  • Nicorette Quick Spray Slows Decline but Cannot Reverse Losses
  • Recigar Reimbursement Channels Quitters to Medical Supervision
    • CHART 120 Recigar Reinforces Structural Displacement
    • CHART 121 Value Sales 2021-2031
    • CHART 122 Value Sales by Category 2026

What's Next?

  • Prescription Therapies and E-Cigarettes to Shrink Pharmacy-Based Demand
  • Nicotine Gum to Maintain Lead as All Formats Decline
    • CHART 123 Forecast Value Sales 2021-2031
    • CHART 124 Forecast Value Sales by Category 2026-2031

Competitive Landscape

  • Nicorette Retains Dominance as Protocol-Driven Habits Block Rivals
    • CHART 125 Company Shares 2026
    • CHART 126 Brand Shares 2026

Channels

  • Pharmacy Guidance Drives First-Time Nrt Purchases, While E-Commerce Leads Repeat Sales
    • CHART 127 Retail Channels 2021-2026

Economic Context

    • CHART 128 Economic Context for Nrt Smoking Cessation Aids
    • CHART 129 Real GDP Growth 2021-2031
    • CHART 130 Inflation 2021-2031

Consumer Context

    • CHART 131 Consumer Context for Nrt Smoking Cessation Aids
    • CHART 132 Population 2021-2031
    • CHART 133 Population by Generation 2026
    • CHART 134 Consumer Expenditure 2021-2031
  • Country Reports Disclaimer

WOUND CARE IN ITALY

Key Data Insights

  • 2026 Developments
  • Wound Care Summary

Industry Performance

  • Brands Enable Home-Based Chronic Wound Management for Older Adults
  • Brands Compete for Value in Acute Wound Solutions
  • Biomimetic Complex Innovation Redefines Chronic Wound Care at Home
    • CHART 135 Bioepitelia Responds to Growing Demand
    • CHART 136 Value Sales 2021-2031
    • CHART 137 Value Sales by Category 2026

What's Next?

  • Pharmacists to Aid Demand for Home-Based Chronic Wound Solutions
  • Lower-Priced Plasters and Gauze to Erode Branded Value While Advanced Care Grows
    • CHART 138 Forecast Value Sales 2021-2031
    • CHART 139 Forecast Value Sales by Category 2026-2031

Competitive Landscape

  • Pietrasanta Pharma Spa Leverages Specialisation as Pikdare Srl Expands Pharmacist Presence
    • CHART 140 Company Shares 2026
    • CHART 141 Brand Shares 2026

Channels

  • Pharmacy Sustains Leadership as Advanced Care Demands Rise
  • E-Commerce Accelerates Price-Driven Repurchase and Multi-Product Baskets
    • CHART 142 Retail Channels 2021-2026

Economic Context

    • CHART 143 Economic Context for Wound Care
    • CHART 144 Real GDP Growth 2021-2031
    • CHART 145 Inflation 2021-2031

Consumer Context

    • CHART 146 Consumer Context for Wound Care
    • CHART 147 Population 2021-2031
    • CHART 148 Population by Generation 2026
    • CHART 149 Consumer Expenditure 2021-2031
  • Country Reports Disclaimer

SPORTS NUTRITION IN ITALY

Key Data Insights

  • 2026 Developments
  • Sports Nutrition Summary

Key Industry Trends

    • CHART 150 Key Industry Trends for Sports Nutrition

Industry Performance

  • Brands Leverage Protein Positioning to Capture Everyday Consumers
  • Physical and Cognitive Benefits Converge through Creatine'S Science-Backed Messaging
  • Brands Are Redefining Distribution through Digital-First Strategies
    • CHART 151 Value Sales 2021-2031
    • CHART 152 Value Sales by Category 2026

What's Next?

  • Fmcg Brands to Intensify Pressure as Specialist Expertise Differentiates Growth
  • Portfolio Diversification and Performance Focus to Expand Value beyond Protein
    • CHART 153 Analyst Insight for Sports Nutrition
  • Direct-To-Consumer Tactics and Personalisation to Redefine Competition
    • CHART 154 Forecast Value Sales 2021-2031
    • CHART 155 Forecast Value Sales by Category 2026-2031

Competitive Landscape

  • Enervit Spa Sustains Broad Reach While the Hut.Com Ltd Drives Digital Gains
    • CHART 156 Company Shares 2026
    • CHART 157 Brand Shares 2026

Channels

  • Digital-Native Brands Cement Online as the Default for Routine Purchases
  • Supermarkets and Health Specialists Adapt as Destination Trips Decline
    • CHART 158 Retail Channels 2021-2026

Products

  • Barilla and Specialist Brands Respond as Protein Becomes a Daily Priority
    • CHART 159 Sports Nutrition Anchored to Traditional Formats
  • Yamamoto and Brb Italy Extend Creatine'S Appeal with Science-Backed Messaging
    • CHART 160 Creatine Gains Relevance
  • Established Brands Like Enervit Prove Digital Shopping Is Now the Default
    • CHART 161 Enervit Confirms E-Commerce Competitive

Economic Context

    • CHART 162 Economic Context for Sports Nutrition
    • CHART 163 Real GDP Growth 2021-2031
    • CHART 164 Inflation 2021-2031

Consumer Context

    • CHART 165 Consumer Context for Sports Nutrition
    • CHART 166 Population 2021-2031
    • CHART 167 Population by Generation 2026
    • CHART 168 Consumer Expenditure 2021-2031
  • Country Reports Disclaimer

DIETARY SUPPLEMENTS IN ITALY

Key Data Insights

  • 2026 Developments
  • Dietary Supplements Summary

Key Industry Trends

    • CHART 169 Key Industry Trends for Dietary Supplements

Industry Performance

  • Multi-Ingredient Preferences Define Italy'S Dietary Supplements in 2026
  • Consolidated Formulations and Preventive Health Drive Dietary Supplements Growth
  • Product Fragmentation Increases Complexity and Reinforces Pharmacist Trust
    • CHART 170 Value Sales 2021-2031
    • CHART 171 Value Sales by Category 2026

What's Next?

  • Crowded Market to Shift Focus From Ingredient Innovation to Operational Credibility
  • Different Consumer Generations to Reshape Product Design and Communication
  • Pharmacists to Anchor Trust in Italy'S Dietary Supplement Environment
    • CHART 172 Analyst Insight for Dietary Supplements
    • CHART 173 Forecast Value Sales 2021-2031
    • CHART 174 Forecast Value Sales by Category 2026-2031

Competitive Landscape

  • Aboca Spa Leverages Full Integration and Trust to Extend Its Lead
    • CHART 175 Company Shares 2026
    • CHART 176 Brand Shares 2026

Channels

  • Pharmacy Guides First-Time Buyers and Secures Premium Sales
  • E-Commerce Converts Repeat Buyers with Convenience and Price

Products

  • Carnidyn Plus Reshapes Routines with Multi-Benefit Innovation
    • CHART 177 Carnidyn Plus Strengthens Role
  • Aboca Leverages Life Point Platform to Shift Supplements Towards Forward-Thinking Lifestyle Choices
    • CHART 178 Natura Mix Highlights Preventative Health
  • Fragmentation and Formulation Proliferation Heighten Importance of Trusted Brands

Economic Context

    • CHART 179 Economic Context for Dietary Supplements
    • CHART 180 Real GDP Growth 2021-2031
    • CHART 181 Inflation 2021-2031

Consumer Context

    • CHART 182 Consumer Context for Dietary Supplements
    • CHART 183 Population 2021-2031
    • CHART 184 Population by Generation 2026
    • CHART 185 Consumer Expenditure 2021-2031
  • Country Reports Disclaimer

VITAMINS IN ITALY

Key Data Insights

  • 2026 Developments
  • Vitamins Summary

Key Industry Trends

    • CHART 186 Key Industry Trends for Vitamins

Industry Performance

  • Premiumisation, Multivitamin Convergence and Commoditisation Define 2026'S Growth
  • Dual Demand Routes and Premium Resilience Anchor Vitamins' Performance
    • CHART 187 Value Sales 2021-2031
    • CHART 188 Value Sales by Category 2026

What's Next?

  • Pharmacists to Shape Premium Growth as Consumers Seek Tailored Solutions
  • Multivitamin Innovation to Secure Leading Position as Value Outpaces Volume
    • CHART 189 Analyst Insight for Vitamins
  • Private Label Competition to Accelerate Polarisation and Channel Fragmentation
    • CHART 190 Forecast Value Sales 2021-2031
    • CHART 191 Forecast Value Sales by Category 2026-2031

Competitive Landscape

  • Bayer Spa and Haleon Italy Srl Extend Brand Trust with Segmentation and Innovation
    • CHART 192 Company Shares 2026
    • CHART 193 Brand Shares 2026

Channels

  • Pharmacy Leaders Drive Value through Premium Formats and Pharmacist Support
  • E-Commerce Accelerates as a Repurchase Engine for Trusted Brands

Products

  • Supradyn and Ibsa Shape Demand through Differentiation and Clinical Focus
    • CHART 194 Supradyn Targeted Supplementation
    • CHART 195 Multicentrum Leverages Preventative Vitamins
  • Multicentrum and Supradyn Difese Exemplify Prevention-Focused Innovation

Economic Context

    • CHART 196 Economic Context for Vitamins
    • CHART 197 Real GDP Growth 2021-2031
    • CHART 198 Inflation 2021-2031

Consumer Context

    • CHART 199 Consumer Context for Vitamins
    • CHART 200 Population 2021-2031
    • CHART 201 Population by Generation 2026
    • CHART 202 Consumer Expenditure 2021-2031
  • Country Reports Disclaimer

WEIGHT MANAGEMENT AND WELLBEING IN ITALY

Key Data Insights

  • 2026 Developments
  • Weight Management and Wellbeing Summary

Key Industry Trends

    • CHART 203 Key Industry Trends for Weight Management and Wellbeing

Industry Performance

  • Glp-1 Adoption Diverts Spending From Legacy Weight-Loss Products
  • Meal Replacement Leads as Evidence-Based Prevention Reshapes Italy's Weight Management
  • Age-Related Malnutrition Reshapes Demand for Nutrition
    • CHART 204 Value Sales 2021-2031
    • CHART 205 Value Sales by Category 2026

What's Next?

  • Glp-1 Therapies to Redefine Consumer Choices and Value Drivers
  • Nutritional Drinks to Gain Credibility as Supplements Lose Relevance
    • CHART 206 Forecast Value Sales 2021-2031
    • CHART 207 Forecast Value Sales by Category 2026-2031

Competitive Landscape

  • Herbalife Italia Spa Retains Leadership as Rivals Gains From Protein-Driven Demand
    • CHART 208 Company Shares 2026
    • CHART 209 Brand Shares 2026

Channels

  • Pharmacies Defend Core Value as Direct Selling Declines
    • CHART 210 Retail Channels 2021-2026

Products

  • Lombardy Expands Glp-1 Access, Reshaping Consumer Spending
  • Meritene and Fortifit Leverage Clinical Partnerships to Grow
    • CHART 211 Meritene Strengthens Role

Economic Context

    • CHART 212 Economic Context for Weight Management and Wellbeing
    • CHART 213 Real GDP Growth 2021-2031
    • CHART 214 Inflation 2021-2031

Consumer Context

    • CHART 215 Consumer Context for Weight Management and Wellbeing
    • CHART 216 Population 2021-2031
    • CHART 217 Population by Generation 2026
    • CHART 218 Consumer Expenditure 2021-2031
  • Country Reports Disclaimer

HERBAL/TRADITIONAL PRODUCTS IN ITALY

Key Data Insights

  • 2026 Developments
  • Herbal/Traditional Products Summary

Key Industry Trends

    • CHART 219 Key Industry Trends for Herbal/Traditional Products

Industry Performance

  • Traceability and Clinical Validation in Focus Gain Ground in 2026
  • Preventive Positioning and Efficacy Scrutiny Define Growth
  • Herbal Topical Analgesics and Adaptogenic Botanicals Gain Momentum

What's Next?

  • Pharmaceutical Entrants to Raise the Bar for Evidence and Transparency
  • Combination Formulations to Drive Consumer Loyalty through Convenience
  • Regulatory Adaptation and Documentation to Reshape Business Priorities

Competitive Landscape

  • Aboca Spa Leverages Vertical Integration to Secure Leadership
  • Structural Leadership Holds as Bayer Spa Shakes up Herbal Remedies

Channels

  • Pharmacies Reinforce Trust as Digital Channels Gain Relevance

Products

  • Bios Line and Aboca Reinforce Trust through Transparency and Research Partnerships
    • CHART 220 Functional Benefits Back Natural Positioning
  • Zidrax and Ginger-Based Launches Capture Prevention-Focused Demand through Tolerability
  • Brands Accelerate Adaptogen Mainstreaming through Targeted Launches
    • CHART 221 Ashwagandha Gains Relevance

Economic Context

    • CHART 222 Economic Context for Herbal/Traditional Products
    • CHART 223 Real GDP Growth 2021-2031
    • CHART 224 Inflation 2021-2031

Consumer Context

    • CHART 225 Consumer Context for Herbal/Traditional Products
    • CHART 226 Population 2021-2031
    • CHART 227 Population by Generation 2026
    • CHART 228 Consumer Expenditure 2021-2031
  • Country Reports Disclaimer

PAEDIATRIC CONSUMER HEALTH IN ITALY

Key Data Insights

  • 2026 Developments
  • Paediatric Consumer Health Summary

Key Industry Trends

    • CHART 229 Key Industry Trends for Paediatric Consumer Health

Industry Performance

  • Demographic Decline, Budget Pressure and Prevention Shift Define Paediatric Health
  • Paediatric Vitamins Accelerate through Evidence-Based Selection and Professional Endorsement

What's Next?

  • Demographic Decline and Parental Polarisation to Shape Outlook
  • Paediatric Vitamins to Expand as Price-Sensitive Parents Seek Value

Competitive Landscape

  • Angelini and Aboca Consolidate Trust as Shares Stabilise

Channels

  • Pharmacies Retain Leadership as Parents Seek Expert Reassurance
  • E-Commerce Grows as Repeat Purchases Drive Digital Expansion

Products

  • Tachipirina and Kaloba Strengthen Parental Trust with Clinical Evidence
    • CHART 230 Pharmaceutical and Herbal Converge
  • Tachipirina and Grintuss Tailor Solutions to Evolving Parental Needs
    • CHART 231 Natural and Pharmaceutical Serve Different Occasions
  • Artsana Expands as Demographic Headwinds Reshape Priorities

Economic Context

    • CHART 232 Economic Context for Paediatric Consumer Health
    • CHART 233 Real GDP Growth 2021-2031
    • CHART 234 Inflation 2021-2031

Consumer Context

    • CHART 235 Consumer Context for Paediatric Consumer Health
    • CHART 236 Population 2021-2031
    • CHART 237 Population by Generation 2026
    • CHART 238 Consumer Expenditure 2021-2031
  • Country Reports Disclaimer
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!